Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials
- DOI
- 10.1016/j.jaad.2025.05.1422
- Published
- 2025-10
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2025.05.1422,
title = {Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials},
author = {Amy S. Paller and Elaine C. Siegfried and Michael J. Cork and Kenji Kabashima and Peter D. Arkwright and Edyta Gębska and Zhen Chen and Joseph Zahn and Ana B. Rossi},
year = {2025},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2025.05.1422},
url = {https://doi.org/10.1016/j.jaad.2025.05.1422}
}RIS
TY - JOUR TI - Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials AU - Amy S. Paller AU - Elaine C. Siegfried AU - Michael J. Cork AU - Kenji Kabashima AU - Peter D. Arkwright AU - Edyta Gębska AU - Zhen Chen AU - Joseph Zahn AU - Ana B. Rossi PY - 2025 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2025.05.1422 UR - https://doi.org/10.1016/j.jaad.2025.05.1422 ER -
APA
Paller, A. S., Siegfried, E. C., Cork, M. J., Kabashima, K., Arkwright, P. D., Gębska, E., Chen, Z., Zahn, J., & Rossi, A. B. (2025). Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.05.1422
Source records
- crossref · retrieved 2026-09-27T05:59:09.144Z